New hope for advanced colon cancer patients after standard treatments fail
Disease control
Not yet recruiting
This study tests whether reusing a previous drug combination (irinotecan plus cetuximab) works better than the current standard treatment for advanced colorectal cancer that has worsened after two rounds of therapy. Researchers will enroll 150 patients whose cancer has specific g…
Phase: PHASE2 • Sponsor: Gruppo Oncologico Italia Meridionale • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC